1. National Cancer Institute. (2009). Cancer topics: Breast cancer. http://www.cancer.gov/cancertopics/types/breast .
2. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., et al. (2000). Molecular portraits of human breast tumours. Nature, 406(6797), 747–752.
3. Gutierrez, M. C., Detre, S., Johnston, S., Mohsin, S. K., Shou, J. N., Allred, D. C., et al. (2005). Molecular changes in tamoxifen-resistant breast cancer: Relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase. Journal of Clinical Oncology, 23(11), 2469–2476.
4. Riggins, R. B., Schrecengost, R. S., Guerrero, M. S., & Bouton, A. H. (2007). Pathways to tamoxifen resistance. Cancer Letters, 256(1), 1–24.
5. Sporn, M. B., & Lipmann, S. M. (2003). Chemoprevention of cancer. In D. W. Kufe, R. E. Pollack, R. R. Weichselbaum, R. C. Bast, T. S. Gansler, J. F. Holland, et al. (Eds.), Cancer medicine (Vol. 6). BC Decker: Hamilton.